FIELD: chemical and pharmaceutical industry; pediatric sedative.
SUBSTANCE: pediatric sedative containing sodium bromide, magnesium sulfate, motherwort tincture, valerian tincture, citral alcohol solution 1%, fructose, gelatin, ascorbic acid, purified water in the following ratio of ingredients per 1 lozenge: sodium bromide 0.005 g, magnesium sulfate 0 0.01 g, valerian tincture 0.01 ml, motherwort tincture 0.01 ml, citral alcohol solution 1% 0.01 ml, fructose 0.1 g, gelatin 0.2 g, ascorbic acid 0.05 g, purified water to 1.0 g.
EFFECT: invention allows you to expand the arsenal of sedatives for children.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WITH SEDATIVE ACTIVITY (VARIANTS) | 2002 |
|
RU2223091C1 |
| COMPOSITION SHOWING SEDATIVE EFFECT | 1998 |
|
RU2138280C1 |
| COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
| MEDICATION BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD OF OBTAINING THEREOF (VERSIONS) | 2012 |
|
RU2563190C2 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| BIOLOGICALLY ACTIVE DIETARY SUPPLEMENT "ERAMIN" DIETARY SUPPLEMENT ORIGITEA OMOLOZHENIYE | 2010 |
|
RU2435453C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| AGENT ELICITING SEDATIVE, SPASMOLYTIC, ANTI-INFLAMMATORY, CHOLAGOGIC, GENERAL TONIC AND EXPECTORATIVE EFFECT | 2002 |
|
RU2223108C1 |
| METHOD FOR TREATING GLOSSALGIA CASES | 2005 |
|
RU2297233C1 |
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
